Open Multicentre Study of the Safety and Efficacy Against COVID-19 of Nirmatrelvir/Ritonavir in the Adult Population
Clinical trial NCT05601167 · COMPLETED
Trial details
- NCT number
- NCT05601167
- Sponsor
- Promomed, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-17
- Primary completion
- 2022-06-01
- Enrollment
- 264
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.